Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CorMedix Announces Strategic Minority Investment in Talphera
-
Chain Bridge I and CommLoan Announce the Signing of a Letter of Intent to Combine and Create a New Public Company Advancing the Commercial Real Estate Fintech Landscape
-
I-Mab Announces Acceleration of Givastomig Investment and Leadership Appointments
-
Cannabix Technologies to Exhibit at National Safety Council (NSC) Safety Congress and Expo, Denver Colorado
-
Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
-
Dynagas LNG Partners LP Reports Results for the Three and Six Months Ended June 30, 2025
-
Telos Corporation, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening New Locations
-
Vivos Inc. Demonstrates Precision in Precision Radionuclide Therapy
-
UMeWorld Expands Growth Strategy with DAGola China Launch, Biofuel Pilot Plant, and Future SAF Potential
-
REPEAT: CleanCore Solutions Announces Closing of $175,000,420 Private Placement
-
Zeo Energy Corp. to Present at ROTH Capital’s Solar & Storage Symposium at RE+ 25 on September 9, 2025
-
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to October 9, 2025
-
Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives
-
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
-
Edible Garden’s Kick. Sports Nutrition, Sports Nutrition Product of the Year, Introduces Clean Labeled Creatine, Pre and Post Workout Recovery Products, and Bold Flavors Featuring Dubai Chocolate an
-
Chain Bridge I and CommLoan Announce the Signing of a Letter of Intent to Combine and Create a New Public Company Advancing the Commercial Real Estate Fintech Landscape
-
Goodman Wealth Advisors Joins Wedbush Securities Wealth Management
-
Presidio Acquires transACT Technology Solutions to Accelerate Global Expansion and Strengthen Digital Leadership in the UK and Ireland
-
Statement by the Board of Directors of CoinShares regarding the joint merger plan with Odysseus Holdings, Vine Hill Capital Investment Corp., Odysseus Holdings Limited and others
-
SAX Chain Announces October Mainnet Launch, Positions AI Agents as Web3’s Next Revenue Model
-
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
-
Renowned Trial Lawyer Linda Moreno Joins DRC as a Jury Consultant and Strategy Advisor
-
Fly Play hf.: Unit revenue reached a record high for August
-
Real-world evidence supports clinical effectiveness of the neffy® nasal adrenaline spray
-
CoinShares proposes to change listing venue to a public stock market or other exchange in the US through a joint merger plan with Vine Hill Capital, Odysseus Holdings and others, and to carry out a pr
-
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
-
Kroll and StepStone Group Launch Private Credit Benchmarks
-
OnTerra Systems Announces That Its RouteSavvy API PLUS Route Optimization API Is Now Available on Microsoft’s Azure Marketplace
-
Schouw & Co. share buy-back programme, week 36 2025
-
Rectitude Holdings Announces $32.6 Million Standby Equity Purchase Agreement to Launch a Bitcoin Treasury Strategy
-
Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors
-
OSS Receives New Platform Award from Safran Federal Systems
-
Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030
-
Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025
-
Cool Springs Chiropractic Welcomes New Doctor to the Clinic’s Award-Winning Team
-
Refined Energy Corp. and Searchlight Resources Inc. Sign an Amendment to the Option Agreement for the Milner and Basin Properties
-
BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Following Productive Type B (End of Phase 2) Meeting with FDA
-
NeuroNOS Granted FDA Orphan Drug Designation for Glioblastoma, the Most Common and Deadliest Primary Malignant Brain Cancer in Adults
-
Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters with GaN, Built for 480 V Three-Phase Systems
-
Aqua Metals Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
OncoC4 to Present Global Pivotal Phase 3 Trial Design for Next-Generation CTLA-4 Antibody Gotistobart Monotherapy Being Co-Developed with BioNTech in NSCLC at the IASLC 2025 World Conference on Lung C
-
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting
-
Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business Strategy
-
Vaxart Announces Adjournment of Special Meeting of Stockholders
-
Genius Group appoints Saifedean Ammous as Board Advisor
-
Rezolve Ai CEO Engages Wall Street with Packed September Investor Line-Up
-
BullFrog AI’s bfPREP™ and bfLEAP® Platforms Deliver Real-World Impact in Eleison Pharmaceuticals Collaboration
-
Aeries Technology Caps Eight Months of Momentum with Financial Turnaround, AI-Driven GCC Innovation, and Strategic Expansion
-
Juve Stabia’s Romeo Menti Stadium to Host “Final Four” of Italy’s First-Ever Serie A Women’s Cup from September 23-27
-
LM Funding America Announces August 2025 Production and Operational Update
